These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 25744620)

  • 1. Antidepressants and the adolescent brain.
    Cousins L; Goodyer IM
    J Psychopharmacol; 2015 May; 29(5):545-55. PubMed ID: 25744620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents.
    Hetrick S; Merry S; McKenzie J; Sindahl P; Proctor M
    Cochrane Database Syst Rev; 2007 Jul; (3):CD004851. PubMed ID: 17636776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Which SSRIs most effectively treat depression in adolescents?
    DeLucia V; Kelsberg G; Safranek S
    J Fam Pract; 2016 Sep; 65(9):632-4. PubMed ID: 27672691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacotherapy of major depressive disorder in adolescents.
    Masi G; Liboni F; Brovedani P
    Expert Opin Pharmacother; 2010 Feb; 11(3):375-86. PubMed ID: 20102303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of selective serotonin reuptake inhibitors in children and adolescents.
    Wong IC; Besag FM; Santosh PJ; Murray ML
    Drug Saf; 2004; 27(13):991-1000. PubMed ID: 15471506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)].
    Hjalmarsson L; Corcos M; Jeammet P
    Encephale; 2005; 31(3):309-16. PubMed ID: 16142045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using acute tryptophan depletion to investigate predictors of treatment response in adolescents with major depressive disorder: study protocol for a randomised controlled trial.
    Stewart RM; Hood SD; Rao P; Moore JK; Runions KC; Murphy SE; Wong JWY; Zepf FD
    Trials; 2018 Aug; 19(1):434. PubMed ID: 30097056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The selective serotonin reuptake inhibitors controversy in the treatment of depression in children.
    Weller EB; Tucker S; Weller RA
    Curr Psychiatry Rep; 2005 Apr; 7(2):87-90. PubMed ID: 15802083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adolescent angst or true intent? Suicidal behavior, risk, and neurobiological mechanisms in depressed children and teenagers taking antidepressants.
    Morrison J; Schwartz TL
    Int J Emerg Ment Health; 2014; 16(1):247-50. PubMed ID: 25345238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fluoxetine: an update of its use in major depressive disorder in adults].
    Gourion D; Perrin E; Quintin P
    Encephale; 2004; 30(4):392-9. PubMed ID: 15597466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of major depression in adolescents: weighing the evidence of risk and benefit in light of black box warnings.
    Lovrin M
    J Child Adolesc Psychiatr Nurs; 2009 May; 22(2):63-8. PubMed ID: 19490276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuation treatment with antidepressants in child and adolescent major depression.
    Ryan ND
    Am J Psychiatry; 2008 Apr; 165(4):411-2. PubMed ID: 18381908
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of the Effects of Antidepressants with Different Mechanisms of Action on Efficacy, Cognitive Functions and Side Effects.
    Erdoğan Ç; Özdemir Rezaki H; Koçak OM; Buturak ŞV
    Turk Psikiyatri Derg; 2020; 31(2):90-98. PubMed ID: 32594496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressants for people with epilepsy and depression.
    Maguire MJ; Marson AG; Nevitt SJ
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drug treatment of depression in children and adolescents].
    Grøholt B
    Tidsskr Nor Laegeforen; 2011 Nov; 131(22):2243-5. PubMed ID: 22085951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics associated with the prescribing of SSRI medication in adolescents with major unipolar depression.
    Cousins L; Whitaker KJ; Widmer B; Midgley N; Byford S; Dubicka B; Kelvin R; Reynolds S; Roberts C; Holland F; Barrett B; Senior R; Wilkinson P; Target M; Fonagy P; Goodyer IM
    Eur Child Adolesc Psychiatry; 2016 Dec; 25(12):1287-1295. PubMed ID: 27125818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.
    Goodyer IM; Dubicka B; Wilkinson P; Kelvin R; Roberts C; Byford S; Breen S; Ford C; Barrett B; Leech A; Rothwell J; White L; Harrington R
    Health Technol Assess; 2008 May; 12(14):iii-iv, ix-60. PubMed ID: 18462573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological treatment of children and adolescents with depression.
    Vitiello B; Ordóñez AE
    Expert Opin Pharmacother; 2016 Dec; 17(17):2273-2279. PubMed ID: 27690663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SSRIs, suicide and violent behavior: is there a need for a better definition of the depressive state?
    Henry C; Demotes-Mainard J
    Curr Drug Saf; 2006 Jan; 1(1):59-62. PubMed ID: 18690915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The place of selective serotonin reuptake inhibitors (SSRIs) in the treatment of depressive disorders in children and adolescents. Recommendations of the Main Board of the Polish Psychiatric Association. Part 1 - Clinical efficacy and areas of application.
    Janas-Kozik MH; Słopień A; Remberk B; Siwek M
    Psychiatr Pol; 2023 Oct; 57(5):899-916. PubMed ID: 38345118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.